{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362825895677896576.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1002/hep.22323"}},{"identifier":{"@type":"URI","@value":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.22323"}},{"identifier":{"@type":"URI","@value":"https://journals.lww.com/01515467-200807000-00014"}}],"dc:title":[{"@value":"Entecavir therapy for lamivudine‐refractory chronic hepatitis B"}],"dcterms:alternative":[{"@value":"Improved virologic, biochemical, and serology outcomes through 96 weeks†"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382825895677896583","@type":"Researcher","foaf:name":[{"@value":"Morris Sherman"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895677896585","@type":"Researcher","foaf:name":[{"@value":"Cihan Yurdaydin"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895677896577","@type":"Researcher","foaf:name":[{"@value":"Halis Simsek"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895677896578","@type":"Researcher","foaf:name":[{"@value":"Marcelo Silva"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895677896704","@type":"Researcher","foaf:name":[{"@value":"Yun‐Fan Liaw"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895677896705","@type":"Researcher","foaf:name":[{"@value":"Vinod K. Rustgi"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895677896576","@type":"Researcher","foaf:name":[{"@value":"Hoel Sette"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895677896582","@type":"Researcher","foaf:name":[{"@value":"Naoky Tsai"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895677896580","@type":"Researcher","foaf:name":[{"@value":"Daniel J. Tenney"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895677896579","@type":"Researcher","foaf:name":[{"@value":"James Vaughan"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895677896584","@type":"Researcher","foaf:name":[{"@value":"Bruce Kreter"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895677896581","@type":"Researcher","foaf:name":[{"@value":"Robert Hindes"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"02709139"}],"prism:publicationName":[{"@value":"Hepatology"}],"dc:publisher":[{"@value":"Ovid Technologies (Wolters Kluwer Health)"}],"prism:publicationDate":"2008-07","prism:volume":"48","prism:number":"1","prism:startingPage":"99","prism:endingPage":"108"},"reviewed":"false","dc:rights":["http://doi.wiley.com/10.1002/tdm_license_1.1"],"url":[{"@id":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.22323"},{"@id":"https://journals.lww.com/01515467-200807000-00014"}],"createdAt":"2008-06-08","modifiedAt":"2024-12-01","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360565168116348928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"JSH Guidelines for the Management of Hepatitis B Virus Infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567185710649216","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Recommendation of lamivudine‐to‐entecavir switching treatment in chronic hepatitis B responders: Randomized controlled trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679771619840","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Two cases of acute hepatitis due to hepatitis E virus that are indigenous to Kitakyushu: a case report"},{"@language":"ja","@value":"北九州に土着したE型肝炎ウイルス株による急性肝炎の2例"},{"@value":"B型肝炎治療ガイドライン(第1.1版)"},{"@language":"ja-Kana","@value":"Bガタ カンエン チリョウ ガイドライン(ダイ1.1ハン)"},{"@language":"ja-Kana","@value":"キタキュウシュウ ニ ドチャク シタ Eガタ カンエンウイルスカブ ニ ヨル キュウセイ カンエン ノ 2レイ"},{"@value":"Guidelines for the management of hepatitis B virus infection"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1002/hep.22323"},{"@type":"CROSSREF","@value":"10.1111/hepr.12269_references_DOI_U4qezerQPeNJBbC8XbU0z5K0gcO"},{"@type":"CROSSREF","@value":"10.1111/j.1872-034x.2011.00807.x_references_DOI_U4qezerQPeNJBbC8XbU0z5K0gcO"},{"@type":"CROSSREF","@value":"10.2957/kanzo.54.402_references_DOI_U4qezerQPeNJBbC8XbU0z5K0gcO"}]}